MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.
Help us keep the database complete and up to date!
If you know of an MPT product not included in the database or have updated information for listed products, please contact us using the “MPT Database Feedback” form.
Check out the MPT products in the development pipeline – view an MPT Pipeline Table by Indication Combination.
Product TypeDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

32 product(s) found

Results: 7 product(s) found
Product Name
Product Type
Delivery Route
Delivery Method
Active Ingredient
Developer
Stage
Indication(s)
Amphora Gel MPT in Development Topical Gel-Vaginal
  • Acidform
  • Evofem Inc.
  • C1
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • Griffithsin (GRFT) in Carrageenan gel (PC-6500) MPT in Development Topical Gel-Vaginal
  • Griffithsin (GRFT)
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • Griffithsin Gel MPT in Development Topical Gel-Rectal
  • Griffithsin (GRFT)
  • University of Louisville
  • P1
  • Chlamydia
  • HIV
  • HSV-2
  • NOV-1003 MPT in Development Topical Gel-Vaginal P1
  • HIV
  • HSV-2
  • Pregnancy
  • poly-[1,4-phenylene-(1-carboxy) methylene] (PPCM) SAMMA Gel MPT in Development Topical Gel-Vaginal
  • poly-[1,4-phenylene-(1-carboxy) methylene
  • Yaso Biotechnologies
  • P1
  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • SR-2P Gel MPT in Development Topical Gel-Vaginal
  • Acyclovir
  • SR-2P (Bioadhesive Polymer Gel)
  • Tenofovir (TFV)
  • SRI International
  • P1
  • HIV
  • HSV-2
  • VivaGel® MPT in Development Topical Gel-Vaginal
  • SPL7013 (Sulphonated Dendrimer)
  • StarPharma Holdings Limited
  • P2
  • Bacterial Vaginosis (BV)
  • HIV
  • HSV-2
  • IMPT Secretariat
    308 Natoma Street
    Suite 150
    Folsom, CA 95630
    916-932-4785 | This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2016, The IMPT. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to women’s reproductive health and empowerment. CAMI Health is housed at the Public Health Institute (PHI).